Interim report, May 1 - October 31, 2000

Interim report, May 1 - October 31, 2000 - Order bookings, excluding divested IGS operations, increased 46 percent to SEK 995 M (679). - Loss before taxes amounted to SEK 24 M (loss: 58), an improvement of SEK 34 M. - Net sales amounted to SEK 884 M (816). For additional information, contact: Lars Jonsteg, Vice President, Corporate Relations, Elekta AB (publ) tel. +46 8 587 254 82 More information about Elekta is available at ------------------------------------------------------------ This information was brought to you by Waymaker The following files are available for download: The full report

About Us

Elekta is proud to be the leading innovator of equipment and software used to improve, prolong and save the lives of people with cancer and brain disorders. Our advanced, effective solutions are created in collaboration with customers, and more than 6,000 hospitals worldwide rely on Elekta technology. Our treatment solutions and oncology informatics portfolios are designed to enhance the delivery of radiation therapy, radiosurgery and brachytherapy, and to drive cost efficiency in clinical workflows. Elekta employs 3,700 people around the world. Headquartered in Stockholm, Sweden, Elekta is listed on NASDAQ Stockholm.


Documents & Links